Navigation Links
Sonitus Medical Technology Ranks #1 on Cleveland Clinic's 'Top 10' Medical Innovations for 2010
Date:10/12/2009

SAN MATEO, Calif., Oct. 13 /PRNewswire/ -- Sonitus Medical, Inc., a medical device company developing the world's first non-surgical and removable hearing device to transmit sound via the teeth, today announced that technology it developed was ranked #1 on Cleveland Clinic's Top 10 Medical Innovations for 2010. The SoundBite(TM) hearing system is an investigational new bone conduction device intended initially for single sided deafness (SSD), a usually permanent condition.

The 'Top 10' list was unveiled last week during Cleveland Clinic's 2009 Medical Innovation Summit. Selected by a panel of Cleveland Clinic physicians and scientists, the list features a wide range of breakthrough techniques, devices, and therapies that are being developed to treat everything from deafness and Parkinson's disease to pneumonia and sleep disorders.

Among the major criteria that served as the basis for qualifying and selecting the Top 10 Medical Innovations were the following:

  • Have significant potential for short-term clinical impact (either a major improvement in patient benefit or an improved function that enhances healthcare delivery).
  • Have a high probability of success.
  • Have sufficient data available to support its nomination.

"We are thrilled that technology developed by Sonitus Medical came out on top of this broad ranging list of medical innovations," said Amir Abolfathi, CEO of Sonitus Medical. "It is an honor to be recognized by such a leading institution as the Cleveland Clinic. We look forward to our SoundBite hearing system making an impact in the coming year as we plan to complete our clinical trial process so we can better serve the 9 million patients who currently suffer from single sided deafness in the US alone."

Causes of single sided deafness, sometimes called unilateral sensorineural hearing loss, can include sudden hearing loss or sudden deafness, trauma, diseases, infections, or other inner ear problems.

To view the full list of medical innovations or for more information about this year's Cleveland Clinic Medical Innovation Summit, visit http://www.clevelandclinic.org/innovations/summit/top10_2010.htm.

About SoundBite(TM)

SoundBite hearing system is the world's first and only non-surgical and removable hearing solution designed to imperceptibly transmit sound via the teeth to help people who are essentially deaf in one ear regain spatial hearing ability and rejoin the conversation of life. It employs a well-established principle called bone conduction to deliver clear, high quality sound to the inner ear. Nearly invisible when worn, the SoundBite system consists of an easy to insert and remove ITM (in-the-mouth) hearing device--which is custom made to fit around either the upper left or right back teeth--and a small microphone unit worn behind the ear. No modifications to the teeth are required. This system is currently for investigational use only with clinical trials now underway intended to support an initial filing for FDA 510(k) clearance to treat single sided deafness. Intended future indications include conductive and mixed hearing loss.

About Sonitus Medical

Sonitus Medical, Inc. is a privately held medical device company developing the SoundBite(TM) hearing system, a non-surgical and removable hearing solution that imperceptibly transmits sound via the teeth. Relying on the principle of bone conduction, this nearly invisible ITM (in-the-mouth) hearing and communication platform is currently for investigational use only and is initially intended as a simple and non-invasive treatment for hearing disorders such as single sided deafness, conductive and/or mixed hearing loss and tinnitus. Potential future applications include consumer and covert communications. Founded in June 2006, Sonitus Medical is headquartered in San Mateo, California. To learn more about Sonitus Medical, please visit www.sonitusmedical.com.

SOURCE Sonitus Medical, Inc.


'/>"/>
SOURCE Sonitus Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 27, 2017   Pulmatrix, Inc . (NASDAQ: PULM), a ... serious pulmonary diseases, today announced that it has added two ... and asthma to its Scientific Advisory Board . ... Richard B. Moss , MD, former chief of the Pediatric ... Fibrosis Center at Stanford University, and ...
(Date:3/27/2017)... , March 27, 2017 ... to reach USD 16.0 billion by 2025, according to ... growing prevalence of chronic diseases is anticipated to be ... analyzers, which thereby widens the scope for growth during ... and bariatric population, which is highly susceptible to chronic ...
(Date:3/27/2017)... BOSTON , March 27, 2017  Allergan ... and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical ... innovative therapies based upon tetracycline chemistry, announced that ... the treatment of moderate to severe acne met ... a once-daily, oral, narrow spectrum tetracycline-derived antibiotic with ...
Breaking Medicine Technology:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... announces today that the University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® ... Western Pennsylvania. , The program, developed in association with efforts by the American ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... leading physicians, Paul Yost, will begin serving as new board chair for Orange ... month. Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s term, ...
(Date:3/28/2017)... ... 2017 , ... In its ongoing effort to educate consumers ... and published an informational resource that addresses frequently asked questions. , “ ... site’s team of third party administrator (TPA) contributors regularly receives as employers, benefit ...
(Date:3/28/2017)... Santa Monica, CA (PRWEB) , ... March 28, ... ... expert, Dr. Carson Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer ... newest gastric balloon procedure, and this procedure adds to SkyLex Advanced Surgical’s ...
(Date:3/28/2017)... ... ... a common and unwelcomed occurrence in people of all ages, genders and ethnicities. Dermatologist Dr. ... of dealing with excess skin oil. “Oily skin is a challenge to many of my ... the oily shine while keeping the skin fresh and clean,” says Dr. Au. , What ...
Breaking Medicine News(10 mins):